Darzalex faspro 1,800MG-30,000 15ML
Ended Awarded
- Contract number
- SPE2DB26FNNVD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,941
Award facts
- Contract value 100% obligated
- $17,940.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product, with a ceiling value of $17,940.60. This firm fixed-price delivery order, issued on November 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded without set-aside designation and is scheduled for completion by November 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. DARZALEX FASPRO is a specialty oncology medication used in the treatment of multiple myeloma, reflecting the company's role in supplying specialized pharmaceuticals across multiple therapeutic domains. This delivery order exemplifies AmerisourceBergen's participation in the broader DLA Pharmaceutical Prime Vendor Global Program, which facilitates the efficient distribution of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB26FNNVD?
SPE2DB26FNNVD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DB26FNNVD worth?
The government has obligated $17,941 on SPE2DB26FNNVD.
Is contract SPE2DB26FNNVD an order under another contract?
Yes. SPE2DB26FNNVD is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB26FNNVD competed?
The extent of competition for SPE2DB26FNNVD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award